I-2-Hydroxy-5-Methylpyridine CAS 1003-68-5 Ubumsulwa ≥99.0% I-Pirfenidone Intermediate Factory

Incazelo emfushane:

Igama Lekhemikhali: 2-Hydroxy-5-Methylpyridine

Amazwi afanayo: 5-Methyl-2(1H)-Pyridinone

I-CAS: 1003-68-5

Ubumsulwa: ≥99.0%

Ukubukeka: Okumhlophe Okumhlophe ukuya Kokuphuzi I-Crystalline Powder

I-Intermediate ye-Pirfenidone (CAS: 53179-13-8) yokwelapha i-Idiopathic Pulmonary Fibrosis (IPF)

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Ukunikezwa Komkhiqizi, Ukuhlanzeka Okuphezulu, Ukukhiqizwa Kwezohwebo
Igama Lekhemikhali: 2-Hydroxy-5-Methylpyridine
I-CAS: 1003-68-5

Chemical Properties:

Igama Lekhemikhali I-2-Hydroxy-5-Methylpyridine
Omqondofana I-5-Methyl-2(1H)-Pyridinone;I-2-Hydroxy-5-Picoline;I-6-Hydroxy-3-Picoline;I-5-Methyl-2-Pyridinol
Inombolo ye-CAS 1003-68-5
Inombolo yeCAT I-RF-PI549
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula C6H7NO
Isisindo samangqamuzana 109.13
I-Melting Point 183.0 kuye ku-187.0 ℃ (lit.)
Ukuncibilika I-Soluble ku-Methanol
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka I-Off-White to Yellow Crystalline Powder
Ubumsulwa ≥99.0%
Okuqukethwe Komswakama (KF) ≤0.50%
Izinsalela ekushiseni ≤0.50%
Noma Ikuphi Ukungcola Okukodwa ≤0.50%
Ukungcola Okuphelele ≤1.00%
Izincibilikisi Ezisele
n-Butanol ≤0.30%
I-Ethanol ≤0.30%
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Pirfenidone emaphakathi (CAS: 53179-13-8)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

1

I-FAQ:

Isicelo:

I-2-Hydroxy-5-Methylpyridine (i-CAS: 1003-68-5) isetshenziswa njengendawo ephakathi yemithi ye-Pirfenidone (CAS: 53179-13-8).I-Pirfenidone (PFD) iwuhlobo lwenoveli lwama-pyridine ketone anomphumela obanzi we-anti-fibrotic, okwazi ukuvimbela nokubuyisela emuva ukwakheka kwe-fibrosis nesibazi.Yangena emakethe e-Shionogi, e-Japan ngo-2008 futhi yagunyazwa yi-US Food and Drug Administration.Uwumuthi wokuqala odlule ezivivinyweni zomtholampilo zesigaba sesi-III (okuhlanganisa ukuphindaphinda, okungahleliwe, nokulawulwa kwe-placebo) obonise ukusebenza kahle kwawo ekwelapheni i-idiopathic pulmonary fibrosis (IPF);ngaphezu kwalokho, isidakamizwa sisebenza kahle kakhulu ekwelapheni ezinye izifo ze-fibrotic ezifana ne-renal interstitial fibrosis kanye ne-fibrosis yesibindi.

Bhala umyalezo wakho lapha futhi usithumelele wona